Responses
Epidemiology and outcomes
Original research
Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
Compose a Response to This Article
Other responses
No responses have been published for this article.